• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Prothena Corp (NQ: PRTA )

    19.83 -0.54 (-2.65%)
    Streaming Delayed Price Updated: 12:02 PM EDT, Jun 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Prothena Corp

    < Previous 1 2 3 4 5 6 7 Next >
    Recap: Prothena Corp Q2 Earnings
      Prothena Corp (NASDAQ:PRTA) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Jim Cramer Says This Company Is A Great One
    On CNBC’s "Mad Money Lightning Round," Jim Cramer said Woodside Energy Group Ltd (NYSE: WDS) is a great company, with a great yield. 
    Via Benzinga
    The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    A Preview Of Prothena Corp's Earnings
    Prothena Corp (NASDAQ:PRTA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Prothena Corp... 
    Via Benzinga
    Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
    Prothena Corporation plc (NASDAQ: PRTA)  
    Via Benzinga
    Recap: Prothena Corp Q4 Earnings
    Prothena Corp (NASDAQ:PRTA) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Earnings Scheduled For February 17, 2022
    Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. 
    Via Benzinga
    Earnings Scheduled For August 8, 2022
    Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter. 
    Via Benzinga
    Analyst Ratings For Prothena Corp
    Within the last quarter, Prothena Corp (NASDAQ:PRTA) has observed the follo... 
    Via Benzinga
    Expert Ratings For Prothena Corp
    Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA 
    Via Benzinga
    Why RBC Capital Sees 'Multiple High-Risk' On This Neurology-Focused Stock
    RBC Capital Markets writes that Prothena Corporation plc (NASDAQ: PRTA) believes that the recent stock downside provides an entry point and that progress with the programs and improved sentiment in the... 
    Via Benzinga
    10 Biggest Price Target Changes For Monday
    Morgan Stanley boosted Archer-Daniels-Midland Company (NYSE: ADM) price target from $69 to $94. Archer-Daniels-Midland shares fell 0.5% to $89.10 in pre-market trading. 
    Via Benzinga
    Prothena Receives FDA Fast Track Designation for PRX012 for the Treatment of Alzheimer's Disease
    Prothena Corporation plc (NASDAQ: PRTA) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-amyloid beta (Aβ) antibody therapy drug candidate... 
    Via Benzinga
    The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Agios's Metabolic Disorder Treatment Receives FDA Approval (NASDAQ: AGIO... 
    Via Benzinga
    Expert Ratings For Prothena Corp
    Analysts have provided the following ratings for Prothena Corp (NASDAQ:PRTA 
    Via Benzinga
    The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... 
    Via Benzinga
    The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
    Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
    Via Benzinga
    Why Jim Cramer Prefers This Mining Stock Over Vale
    On CNBC’s "Mad Money Lightning Round," Jim Cramer said ChargePoint Holdings, Inc. (NYSE: 
    Via Benzinga
    The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Says Lead Monoclonal Antibody Effective Against Omicron Variant Adagio... 
    Via Benzinga
    4 Stocks Insiders Are Buying
    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers Biomerica (NASDAQ:BMRA) stock inc... 
    Via Benzinga
    50 Biggest Movers From Yesterday
    Gainers electroCore, Inc. (NASDAQ: ECOR) shares jumped 64% to settle at $0.88 on Wednesday after the company's gammaCore nVNS device received FDA Breakthrough Designation for... 
    Via Benzinga
    28 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Immuron Limited (NASDAQ: IMRN) shares jumped 40.2% to $3.5887. Immuron received funding of A$6.2 ($4.45) million from the U.S Department of Defense to examine a dosing... 
    Via Benzinga
    Mid-Morning Market Update: Markets Open Higher; US Inflation Rate Rises To 7% In December
    Following the market opening Wednesday, the Dow traded up 0.56% to 36,453.49 while the NASDAQ rose 0.79% to 15,273.08. The S&P also rose, gaining, 0.60% to 4,741.45. The U.S.... 
    Via Benzinga
    Best Stocks Of 2021: Meme Stocks, Biotechs Highlight Broad Sector Strength
    The list features stocks from diverse sectors as the economy recovers from the pandemic. 
    Via Investor's Business Daily
    7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
    These seven drug stocks, a mix of growth, value, and moonshot plays, each stand to see big moves in the next twelve months. 
    Via InvestorPlace
    Exposures COVID-19
    7 A-Rated Biotechs to Buy for the Long Run
    The one thing the pandemic has shown us is biotechs are changing the way we treat diseases. These A-rated biotechs are great examples. 
    Via InvestorPlace
    Prothena Corp: Q3 Earnings Insights
    Prothena Corp (NASDAQ:PRTA) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
    Via Benzinga
    7 A-Rated Healthcare Stocks to Buy for the Long Haul
    It looks like we're on the back end of the Covid pandemic, so it's a good time to look at healthcare stocks that have a big future. 
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
    Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE: 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.